股本结构
单位：万股
| 公告日期 | 2025-11-04 | 2025-11-04 | 2025-08-07 | 2025-08-07 | 2025-04-29 | 2025-04-29 |
|---|---|---|---|---|---|---|
| 证券总股本 | 5629.07 | 5628.33 | 5625.76 | 5625.30 | 5618.31 | 5617.91 |
| 普通股本 | 5629.07 | 5628.33 | 5625.76 | 5625.30 | 5618.31 | 5617.91 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-10-31 | 2025-09-30 | 2025-08-04 | 2025-06-30 | 2025-04-25 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-04 | 5629.07 | 未披露 | 定期报告 | 2025-10-31 |
| 2025-11-04 | 5628.33 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
|
2025-09-30 |
| 2025-08-07 | 5625.76 | 未披露 | 定期报告 | 2025-08-04 |
| 2025-08-07 | 5625.30 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to contingent consideration earnout payments
|
2025-06-30 |
| 2025-04-29 | 5618.31 | 未披露 | 定期报告 | 2025-04-25 |
| 2025-04-29 | 5617.91 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
|
2025-03-31 |
| 2025-04-04 | 5617.91 | 未披露 | 定期报告 | 2025-03-24 |
| 2025-04-04 | 5614.86 | 未披露 | 定期报告 | 2025-03-07 |
| 2025-03-14 | 5609.17 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to contingent consideration earnout payments
Conversion of debt
|
2024-12-31 |
| 2024-11-18 | 5602.67 | 未披露 |
更多>>
From June 30,2024 to September 30,2024
Conversion of debt
Exercise of stock options and vesting of stock
Tax withholding on vesting of restricted stock units
|
2024-09-30 |
| 2024-07-30 | 5600.65 | 未披露 | 定期报告 | 2024-07-26 |
| 2024-07-30 | 5590.29 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to contingent consideration earnout payments
Conversion of debt
|
2024-06-30 |
| 2024-05-01 | 5587.59 | 未披露 | 定期报告 | 2024-04-29 |
| 2024-05-01 | 5584.13 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to contingent consideration earnout payment
|
2024-03-31 |
| 2024-04-01 | 5583.85 | 未披露 | 定期报告 | 2024-03-18 |
| 2024-02-22 | 5577.11 | 未披露 | 定期报告 | 2024-02-16 |
| 2024-02-22 | 5576.61 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Repurchase of common stock
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock
Issuance of common stock pursuant to the acquisition of FlexBiosys, Inc.
Issuance of common stock pursuant to the acquisition of Metenova Holding AB
Issuance of common stock pursuant to the Avitide,Inc. contingent consideration earnout payment
|
2023-12-31 |
| 2023-10-31 | 5583.20 | 未披露 | 定期报告 | 2023-10-27 |
| 2023-10-31 | 5577.47 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock for debt conversion
|
2023-09-30 |
| 2023-08-02 | 5575.63 | 未披露 | 定期报告 | 2023-07-31 |
| 2023-08-02 | 5574.49 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to the acquisition of FlexBiosys, Inc.
Issuance of common stock pursuant to the Avitide, Inc. contingent consideration earnout payment
|
2023-06-30 |
| 2023-05-02 | 5568.00 | 未披露 | 定期报告 | 2023-04-28 |
| 2023-05-02 | 5564.43 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
|
2023-03-31 |
| 2023-04-11 | 5564.42 | 未披露 | 定期报告 | 2023-03-20 |
| 2023-02-22 | 5556.26 | 未披露 | 定期报告 | 2023-02-17 |
| 2023-02-22 | 5555.77 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock
Issuance of common stock for debt conversion
|
2022-12-31 |
| 2022-11-01 | 5552.44 | 未披露 | 定期报告 | 2022-10-28 |
| 2022-11-01 | 5551.96 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
|
2022-09-30 |
| 2022-08-02 | 5549.12 | 未披露 | 定期报告 | 2022-07-29 |
| 2022-08-02 | 5546.59 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
|
2022-06-30 |
| 2022-04-27 | 5543.32 | 未披露 | 定期报告 | 2022-04-25 |
| 2022-04-11 | 5542.91 | 未披露 | 定期报告 | 2022-04-01 |
| 2022-04-27 | 5542.90 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
|
2022-03-31 |
| 2022-02-17 | 5532.75 | 未披露 | 定期报告 | 2022-02-14 |
| 2022-02-17 | 5532.15 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Issuance of common stock pursuant to the acquisition of Avitide Inc.
Tax withholding on vesting of restricted stock
|
2021-12-31 |
| 2021-10-28 | 5528.85 | 未披露 | 定期报告 | 2021-10-25 |
| 2021-10-28 | 5528.40 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Issuance of common stock pursuant to the acquisition of Avitide Inc.
Tax withholding on vesting of restricted stock units
|
2021-09-30 |
| 2021-07-27 | 5497.72 | 未披露 | 定期报告 | 2021-07-23 |
| 2021-07-27 | 5496.95 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of stock options and vesting of stock units
|
2021-06-30 |
| 2021-05-04 | 5490.45 | 未披露 | 定期报告 | 2021-04-30 |
| 2021-04-21 | 5489.92 | 未披露 | 定期报告 | 2021-04-01 |
| 2021-05-04 | 5489.92 | 未披露 |
更多>>
from December 31, 2020 to March 31, 2021
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
|
2021-03-31 |
| 2021-02-24 | 5477.13 | 未披露 | 定期报告 | 2021-02-19 |
| 2021-02-24 | 5476.08 | 未披露 |
更多>>
From December 31,2019 to December 31,2020
Issuance of common stock pursuant to the acquisition of ARTeSYN Biosolutions
Proceeds from issuance of common stock, net of issuance costs of $400,000
Exercise of stock options and vesting of stock units
|
2020-12-31 |
| 2020-12-10 | 5410.67 | 未披露 |
更多>>
1.Common Stock Offered by the company 1,500,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 52,606,700 shares outstanding as of September 30, 2020.
|
2020-12-10 |
| 2020-11-05 | 5261.93 | 未披露 | 定期报告 | 2020-11-02 |
| 2020-11-05 | 5260.67 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Exercise of stock options and vesting of stock units
|
2020-09-30 |
| 2020-07-30 | 5250.26 | 未披露 | 定期报告 | 2020-07-27 |
| 2020-07-30 | 5249.49 | 未披露 |
更多>>
from March 31, 2020 to June 30, 2020
Exercise of stock options and vesting of stock units
|
2020-06-30 |
| 2020-05-06 | 5230.57 | 未披露 | 定期报告 | 2020-05-04 |
| 2020-05-06 | 5227.81 | 未披露 |
更多>>
from December 31, 2019 to March 31, 2020
Exercise of stock options and releases of restricted stock
|
2020-03-31 |
| 2020-02-26 | 5208.36 | 未披露 | 定期报告 | 2020-02-18 |
| 2020-02-26 | 5207.83 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of common stock for debt conversion
Exercise of stock options and releases of restricted stock
Issuance of common stock pursuant to the acquisition of C Technologies, Inc.
Tax withholding on vesting of restricted stock
Proceeds from issuance of common stock, net of issuance costs of $18,607
|
2019-12-31 |
| 2019-10-31 | 5205.89 | 未披露 | 定期报告 | 2019-10-28 |
| 2019-10-31 | 5205.26 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of common stock for debt conversion
Exercise of stock options and releases of restricted stock
Tax withholding on vesting of restricted stock units
Proceeds from issuance of common stock, net of issuance costs of $6,981
|
2019-09-30 |
| 2019-08-01 | 5153.08 | 未披露 | 定期报告 | 2019-07-30 |
| 2019-07-19 | 4545.40 | 未披露 | 定期报告 | 2019-07-19 |
| 2019-08-01 | 4808.64 | 未披露 |
更多>>
from March 31, 2019 to June 30, 2019
Issuance of common stock for debt conversion
Exercise of stock options and releases of restricted stock
Issuance of common stock pursuant to the acquisition of C Technologies, Inc
Proceeds from issuance of common stock, net of issuance costs of $0.5 million
|
2019-06-30 |
| 2019-05-09 | 4722.54 | 未披露 | 定期报告 | 2019-05-03 |
| 2019-05-09 | 4407.40 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Exercise of stock options and vesting of restricted stock
|
2019-03-31 |
| 2019-04-18 | 4407.40 | 未披露 | 定期报告 | 2019-03-29 |
| 2019-03-01 | 4392.15 | 未披露 | 定期报告 | 2019-02-22 |
| 2019-03-01 | 4391.74 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common stock for debt conversion
Exercise of stock options and vesting of restricted stock
|
2018-12-31 |
| 2018-11-01 | 4385.93 | 未披露 | 定期报告 | 2018-10-29 |
| 2018-11-01 | 4385.34 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-08-02 | 4380.58 | 未披露 | 定期报告 | 2018-07-26 |
| 2018-08-02 | 4379.86 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-08 | 4369.39 | 未披露 | 定期报告 | 2018-05-01 |
| 2018-05-08 | 4369.23 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-04-20 | 4369.23 | 未披露 | 定期报告 | 2018-03-23 |
| 2018-02-22 | 4358.85 | 未披露 | 定期报告 | 2018-02-15 |
| 2018-02-22 | 4358.71 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Shares issued in acquisition
Payment of contingent consideration in stock
Proceeds from issuance of common stock, net of issuance costs of $8,691,000
Exercise of stock options and vesting of restricted stock
|
2017-12-31 |
| 2017-11-09 | 4356.53 | 未披露 | 定期报告 | 2017-11-02 |
| 2017-11-09 | 4355.91 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-03 | 3735.61 | 未披露 | 定期报告 | 2017-07-28 |
| 2017-08-03 | 3411.90 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-04 | 3408.07 | 未披露 | 定期报告 | 2017-04-28 |
| 2017-05-04 | 3407.65 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-04-21 | 3407.65 | 未披露 | 定期报告 | 2017-03-30 |
| 2017-02-23 | 3384.55 | 未披露 | 定期报告 | 2017-02-17 |
| 2017-02-23 | 3384.41 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Shares issued in acquisition
Payment of contingent consideration in stock
Exercise of stock options and vesting of restricted stock
|
2016-12-31 |
| 2016-11-03 | 3383.19 | 未披露 | 定期报告 | 2016-10-28 |
| 2016-11-03 | 3382.30 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-04 | 3378.65 | 未披露 | 定期报告 | 2016-07-29 |
| 2016-08-04 | 3369.13 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-05 | 3363.86 | 未披露 | 定期报告 | 2016-04-29 |
| 2016-05-05 | 3309.79 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-02-25 | 3303.15 | 未披露 | 定期报告 | 2016-02-18 |
| 2016-02-25 | 3294.94 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Exercise of stock options and vesting of restricted stock
|
2015-12-31 |
| 2015-11-05 | 3294.36 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-08-06 | 3291.02 | 未披露 | 定期报告 | 2015-07-31 |
| 2015-08-06 | 3290.30 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-05-08 | 3285.23 | 未披露 | 定期报告 | 2015-05-01 |
| 2015-05-08 | 3285.15 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-17 | 3277.78 | 未披露 | 定期报告 | 2015-03-12 |
| 2015-03-17 | 3277.44 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Shares issued in acquisition
Exercise of stock options
|
2014-12-31 |
| 2014-11-07 | 3272.17 | 未披露 | 定期报告 | 2014-10-16 |
| 2014-11-07 | 3270.31 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-08-11 | 3264.81 | 未披露 | 定期报告 | 2014-07-10 |
| 2014-08-11 | 3265.88 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-05-09 | 3203.99 | 未披露 | 定期报告 | 2014-04-14 |
| 2014-05-09 | 3204.07 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-03-14 | 3193.55 | 未披露 | 定期报告 | 2014-02-12 |
| 2014-03-14 | 3192.57 | 未披露 |
更多>>
from December 31,2012 to December 31,2013
Exercise of stock options
|
2013-12-31 |
| 2013-11-08 | 3190.84 | 未披露 | 定期报告 | 2013-10-23 |
| 2013-11-08 | 3188.30 | 未披露 | 定期报告 | 2013-09-30 |
| 2013-08-07 | 3182.14 | 未披露 | 定期报告 | 2013-07-29 |
| 2013-08-07 | 3181.42 | 未披露 | 定期报告 | 2013-06-30 |
| 2013-05-07 | 3144.29 | 未披露 | 定期报告 | 2013-04-19 |
| 2013-05-07 | 3142.54 | 未披露 | 定期报告 | 2013-03-31 |
| 2013-04-09 | 3131.53 | 未披露 | 定期报告 | 2013-03-22 |
| 2013-03-15 | 3121.95 | 未披露 | 定期报告 | 2013-02-20 |
| 2013-03-15 | 3119.50 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Exercise of stock options
|
2012-12-31 |
| 2012-11-08 | 3111.18 | 未披露 | 定期报告 | 2012-10-30 |
| 2010-11-02 | 3078.73 | 未披露 | 定期报告 | 2010-09-30 |
| 2010-08-05 | 3077.39 | 未披露 | 定期报告 | 2010-06-30 |
| 2010-06-10 | 3076.68 | 未披露 | 定期报告 | 2010-05-31 |
| 2010-06-10 | 3076.18 | 未披露 |
更多>>
from March 31, 2009 to March 31, 2010
Exercise of stock options
|
2010-03-31 |
| 2010-02-04 | 3076.18 | 未披露 | 定期报告 | 2009-12-31 |
| 2009-06-11 | 3074.17 | 未披露 |
更多>>
from March 31, 2008 to March 31, 2009
Repurchase and retirement of treasury stock
Exercise of stock options
|
2009-03-31 |
| 2008-06-13 | 3107.29 | 未披露 |
更多>>
from March 31, 2007 to March 31, 2008
Issuance of common stock for license
Exercise of stock options
|
2008-03-31 |
| 2007-06-08 | 3047.76 | 未披露 |
更多>>
from March 31, 2006 to March 31, 2007
Repurchase and retirement of treasury stock
Exercise of stock options
|
2007-03-31 |
| 2006-06-09 | 3037.76 | 未披露 |
更多>>
from March 31, 2005 to March 31, 2006
Issuance of common stock for services
Deferred compensation related to employee stock options
Exercise of stock options
|
2006-03-31 |
| 2005-06-14 | 3009.44 | 未披露 |
更多>>
from March 31, 2004 to March 31, 2005
Exercise of stock options
|
2005-03-31 |
| 2004-06-14 | 3003.95 | 未披露 | 定期报告 | 2004-06-10 |
| 2004-06-14 | 3003.61 | 未披露 |
更多>>
from March 31, 2003 to March 31, 2004
Sale of common stock, net of issuance costs of $674,965
Issuance of common stock for payment of license
Exercise of stock options and warrants
|
2004-03-31 |
| 2003-06-27 | 2733.90 | 未披露 |
更多>>
from March 31, 2002 to March 31, 2003
Issuance of common stock for payment of license
|
2003-03-31 |
| 2002-05-24 | 2664.28 | 未披露 |
更多>>
from March 31, 2001 to March 31, 2002
Exercise of stock options
|
2002-03-31 |
| 2001-06-29 | 2663.40 | 未披露 | 定期报告 | 2001-06-15 |
| 2001-06-29 | 2662.90 | 未披露 |
更多>>
from March 31, 2000 to March 31, 2001
Issuance of common stock for patent acquisition
Exercise of stock options
Exercise of warrants
|
2001-03-31 |
| 2000-06-23 | 2654.83 | 未披露 | 定期报告 | 2000-06-15 |
| 2000-06-23 | 2631.60 | 未披露 |
更多>>
from March 31,1999 to March 31,2000
Issuance of common stock and warrants
Exercise of stock option
Exercise of warrants
|
2000-03-31 |
| 1999-06-29 | 2186.63 | 未披露 | 定期报告 | 1999-06-23 |
| 1999-06-29 | 1826.43 | 未披露 |
更多>>
from March 31, 1998 to March 31, 1999
Issuance of common stock and warrants
|
1999-03-31 |
| 1998-06-26 | 1800.18 | 未披露 |
更多>>
from March 31, 1997 to March 31, 1998
Retirement of common stock issued in connection with the acquisition of ProsCure, Inc.
Issuance of common stock and warrants, net of issusance costs
|
1998-03-31 |
| 1997-06-02 | 1600.82 | 未披露 |
更多>>
from March 31, 1996 to March 31, 1997
Issuance of common stock in connection with the acquisition of Proscure, Inc.
|
1997-03-31 |
| 1996-06-27 | 1560.25 | 未披露 |
更多>>
from March 31, 1995 to March 31, 1996
Issuance of common stock in connection with the acquisition of Glycan Pharmaceutical, Inc.
Exercise of stock options
|
1996-03-31 |
| 1995-07-17 | 1535.89 | 未披露 | 定期报告 | 1995-06-15 |
| 1995-07-17 | 1535.70 | 未披露 |
更多>>
from March 31, 1994 to March 31, 1995
Contribution of common stock to ESOP
|
1995-03-31 |
| 1995-07-17 | 1530.27 | 未披露 |
更多>>
from March 31, 1993 to March 31, 1994
Exercise of stock options
Sale of common stock, net of issuance costs of $302,034 and underwriters' commissions
|
1994-03-31 |
From June 30, 2025 to September 30, 2025
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
From March 31, 2025 to June 30, 2025
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to contingent consideration earnout payments
From December 31, 2024 to March 31, 2025
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
From December 31, 2023 to December 31, 2024
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to contingent consideration earnout payments
Conversion of debt
From June 30,2024 to September 30,2024
Conversion of debt
Exercise of stock options and vesting of stock
Tax withholding on vesting of restricted stock units
From March 31, 2024 to June 30, 2024
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to contingent consideration earnout payments
Conversion of debt
From December 31, 2023 to March 31, 2024
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to contingent consideration earnout payment
From December 31, 2022 to December 31, 2023
Repurchase of common stock
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock
Issuance of common stock pursuant to the acquisition of FlexBiosys, Inc.
Issuance of common stock pursuant to the acquisition of Metenova Holding AB
Issuance of common stock pursuant to the Avitide,Inc. contingent consideration earnout payment
From June 30, 2023 to September 30, 2023
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock for debt conversion
From March 31, 2023 to June 30, 2023
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
Issuance of common stock pursuant to the acquisition of FlexBiosys, Inc.
Issuance of common stock pursuant to the Avitide, Inc. contingent consideration earnout payment
From December 31, 2022 to March 31, 2023
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
From December 31, 2021 to December 31, 2022
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock
Issuance of common stock for debt conversion
From June 30, 2022 to September 30, 2022
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
From March 31, 2022 to June 30, 2022
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
From December 31, 2021 to March 31, 2022
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Tax withholding on vesting of restricted stock units
From December 31, 2020 to December 31, 2021
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Issuance of common stock pursuant to the acquisition of Avitide Inc.
Tax withholding on vesting of restricted stock
From June 30, 2021 to September 30, 2021
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
Issuance of common stock pursuant to the acquisition of Avitide Inc.
Tax withholding on vesting of restricted stock units
From March 31, 2021 to June 30, 2021
Exercise of stock options and vesting of stock units
from December 31, 2020 to March 31, 2021
Issuance of common stock for debt conversion
Exercise of stock options and vesting of stock units
From December 31,2019 to December 31,2020
Issuance of common stock pursuant to the acquisition of ARTeSYN Biosolutions
Proceeds from issuance of common stock, net of issuance costs of $400,000
Exercise of stock options and vesting of stock units
1.Common Stock Offered by the company 1,500,000 shares.
2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 52,606,700 shares outstanding as of September 30, 2020.
From June 30, 2020 to September 30, 2020
Exercise of stock options and vesting of stock units
from March 31, 2020 to June 30, 2020
Exercise of stock options and vesting of stock units
from December 31, 2019 to March 31, 2020
Exercise of stock options and releases of restricted stock
from December 31, 2018 to December 31, 2019
Issuance of common stock for debt conversion
Exercise of stock options and releases of restricted stock
Issuance of common stock pursuant to the acquisition of C Technologies, Inc.
Tax withholding on vesting of restricted stock
Proceeds from issuance of common stock, net of issuance costs of $18,607
from June 30, 2019 to September 30, 2019
Issuance of common stock for debt conversion
Exercise of stock options and releases of restricted stock
Tax withholding on vesting of restricted stock units
Proceeds from issuance of common stock, net of issuance costs of $6,981
from March 31, 2019 to June 30, 2019
Issuance of common stock for debt conversion
Exercise of stock options and releases of restricted stock
Issuance of common stock pursuant to the acquisition of C Technologies, Inc
Proceeds from issuance of common stock, net of issuance costs of $0.5 million
from December 31, 2018 to March 31, 2019
Exercise of stock options and vesting of restricted stock
from December 31, 2017 to December 31, 2018
Issuance of common stock for debt conversion
Exercise of stock options and vesting of restricted stock
from December 31, 2016 to December 31, 2017
Shares issued in acquisition
Payment of contingent consideration in stock
Proceeds from issuance of common stock, net of issuance costs of $8,691,000
Exercise of stock options and vesting of restricted stock
From December 31, 2015 to December 31, 2016
Shares issued in acquisition
Payment of contingent consideration in stock
Exercise of stock options and vesting of restricted stock
from December 31, 2014 to December 31, 2015
Exercise of stock options and vesting of restricted stock
from December 31, 2013 to December 31, 2014
Shares issued in acquisition
Exercise of stock options
from December 31,2012 to December 31,2013
Exercise of stock options
from December 31, 2011 to December 31, 2012
Exercise of stock options
from March 31, 2009 to March 31, 2010
Exercise of stock options
from March 31, 2008 to March 31, 2009
Repurchase and retirement of treasury stock
Exercise of stock options
from March 31, 2007 to March 31, 2008
Issuance of common stock for license
Exercise of stock options
from March 31, 2006 to March 31, 2007
Repurchase and retirement of treasury stock
Exercise of stock options
from March 31, 2005 to March 31, 2006
Issuance of common stock for services
Deferred compensation related to employee stock options
Exercise of stock options
from March 31, 2004 to March 31, 2005
Exercise of stock options
from March 31, 2003 to March 31, 2004
Sale of common stock, net of issuance costs of $674,965
Issuance of common stock for payment of license
Exercise of stock options and warrants
from March 31, 2002 to March 31, 2003
Issuance of common stock for payment of license
from March 31, 2001 to March 31, 2002
Exercise of stock options
from March 31, 2000 to March 31, 2001
Issuance of common stock for patent acquisition
Exercise of stock options
Exercise of warrants
from March 31,1999 to March 31,2000
Issuance of common stock and warrants
Exercise of stock option
Exercise of warrants
from March 31, 1998 to March 31, 1999
Issuance of common stock and warrants
from March 31, 1997 to March 31, 1998
Retirement of common stock issued in connection with the acquisition of ProsCure, Inc.
Issuance of common stock and warrants, net of issusance costs
from March 31, 1996 to March 31, 1997
Issuance of common stock in connection with the acquisition of Proscure, Inc.
from March 31, 1995 to March 31, 1996
Issuance of common stock in connection with the acquisition of Glycan Pharmaceutical, Inc.
Exercise of stock options
from March 31, 1994 to March 31, 1995
Contribution of common stock to ESOP
from March 31, 1993 to March 31, 1994
Exercise of stock options
Sale of common stock, net of issuance costs of $302,034 and underwriters' commissions